Anxiety symptom trajectories from treatment to 5- to 12-year follow-up across childhood and adolescence / Sunhye BAI in Journal of Child Psychology and Psychiatry, 64-9 (September 2023)  

Public ISBD [article]  inJournal of Child Psychology and Psychiatry > 64-9 (September 2023) . - p.1336-1345 Titre : Anxiety symptom trajectories from treatment to 5- to 12-year follow-up across childhood and adolescence Type de document : Texte imprimé et/ou numérique Auteurs : Sunhye BAI, Auteur ; Benjamin ROLON-ARROYO, Auteur ; John T. WALKUP, Auteur ; Philip C. KENDALL, Auteur ; Golda S. GINSBURG, Auteur ; Courtney P. KEETON, Auteur ; Anne Marie ALBANO, Auteur ; Scott N. COMPTON, Auteur ; Dara SAKOLSKY, Auteur ; John PIACENTINI, Auteur ; Tara S. PERIS, Auteur Article en page(s) : p.1336-1345 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : Objective The current study examined trajectories of anxiety during (a) acute treatment and (b) extended follow-up to better characterize the long-term symptom trajectories of youth who received evidence-based intervention for anxiety disorders using a person-centered approach. Method Participants were 319 youth (age 7-17?years at enrollment), who participated in a multicenter randomized controlled trial for the treatment of pediatric anxiety disorders, Child/Adolescent Anxiety Multimodal Study, and a 4-year naturalistic follow-up, Child/Adolescent Anxiety Multimodal Extended Long-term Study, an average of 6.5?years later. Using growth mixture modeling, the study identified distinct trajectories of anxiety across acute treatment (Weeks 0-12), posttreatment (Weeks 12-36), and the 4-year-long follow-up, and identified baseline predictors of these trajectories. Results Three nonlinear anxiety trajectories emerged: "short-term responders" who showed rapid treatment response but had higher levels of anxiety during the extended follow-up; "durable responders" who sustained treatment gains; and "delayed remitters" who did not show an initial response to treatment, but showed low levels of anxiety during the maintenance and extended follow-up periods. Worse anxiety severity and better family functioning at baseline predicted membership in the delayed remitters group. Caregiver strain differentiated short-term responders from durable responders. Conclusions Findings suggest that initial response to treatment does not guarantee sustained treatment gains over time for some youth. Future follow-up studies that track treated youth across key developmental transitions and in the context of changing social environments are needed to inform best practices for the long-term management of anxiety. En ligne : https://doi.org/10.1111/jcpp.13796 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=512 [article] Anxiety symptom trajectories from treatment to 5- to 12-year follow-up across childhood and adolescence [Texte imprimé et/ou numérique] / Sunhye BAI, Auteur ; Benjamin ROLON-ARROYO, Auteur ; John T. WALKUP, Auteur ; Philip C. KENDALL, Auteur ; Golda S. GINSBURG, Auteur ; Courtney P. KEETON, Auteur ; Anne Marie ALBANO, Auteur ; Scott N. COMPTON, Auteur ; Dara SAKOLSKY, Auteur ; John PIACENTINI, Auteur ; Tara S. PERIS, Auteur . - p.1336-1345. Langues : Anglais (eng) in Journal of Child Psychology and Psychiatry > 64-9 (September 2023) . - p.1336-1345 Index. décimale : PER Périodiques Résumé : Objective The current study examined trajectories of anxiety during (a) acute treatment and (b) extended follow-up to better characterize the long-term symptom trajectories of youth who received evidence-based intervention for anxiety disorders using a person-centered approach. Method Participants were 319 youth (age 7-17?years at enrollment), who participated in a multicenter randomized controlled trial for the treatment of pediatric anxiety disorders, Child/Adolescent Anxiety Multimodal Study, and a 4-year naturalistic follow-up, Child/Adolescent Anxiety Multimodal Extended Long-term Study, an average of 6.5?years later. Using growth mixture modeling, the study identified distinct trajectories of anxiety across acute treatment (Weeks 0-12), posttreatment (Weeks 12-36), and the 4-year-long follow-up, and identified baseline predictors of these trajectories. Results Three nonlinear anxiety trajectories emerged: "short-term responders" who showed rapid treatment response but had higher levels of anxiety during the extended follow-up; "durable responders" who sustained treatment gains; and "delayed remitters" who did not show an initial response to treatment, but showed low levels of anxiety during the maintenance and extended follow-up periods. Worse anxiety severity and better family functioning at baseline predicted membership in the delayed remitters group. Caregiver strain differentiated short-term responders from durable responders. Conclusions Findings suggest that initial response to treatment does not guarantee sustained treatment gains over time for some youth. Future follow-up studies that track treated youth across key developmental transitions and in the context of changing social environments are needed to inform best practices for the long-term management of anxiety. En ligne : https://doi.org/10.1111/jcpp.13796 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=512

Substance use outcomes from the Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS) / Thomas M. OLINO ; Anne Marie ALBANO ; Courtney P. KEETON ; Dara SAKOLSKY ; Boris BIRMAHER ; John PIACENTINI ; Tara S. PERIS ; Scott N. COMPTON ; Elizabeth GOSCH ; Golda S. GINSBURG ; Elizabeth L. PINNEY ; Philip C. KENDALL in Journal of Child Psychology and Psychiatry, 65-7 (July 2024)  

Public ISBD [article]  inJournal of Child Psychology and Psychiatry > 65-7 (July 2024) . - p.910-920 Titre : Substance use outcomes from the Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS) Type de document : Texte imprimé et/ou numérique Auteurs : Thomas M. OLINO, Auteur ; Anne Marie ALBANO, Auteur ; Courtney P. KEETON, Auteur ; Dara SAKOLSKY, Auteur ; Boris BIRMAHER, Auteur ; John PIACENTINI, Auteur ; Tara S. PERIS, Auteur ; Scott N. COMPTON, Auteur ; Elizabeth GOSCH, Auteur ; Golda S. GINSBURG, Auteur ; Elizabeth L. PINNEY, Auteur ; Philip C. KENDALL, Auteur Article en page(s) : p.910-920 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : Background Substance use problems and anxiety disorders are both highly prevalent and frequently cooccur in youth. The present study examined the benefits of successful anxiety treatment at 3-12?years after treatment completion on substance use outcomes (i.e. diagnoses and lifetime expected use). Methods The sample was from the Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS), a naturalistic follow-up study to the Child/Adolescent Anxiety Multimodal Study (CAMS) which randomized youth to cognitive behavioral therapy (CBT; Coping cat), medication (sertraline), their combination, or pill placebo. The first CAMELS visit occurred an average of 6.5?years following CAMS randomization. Participants were 319 youth (65.4% of the CAMS sample), aged 7-17?years at CAMS baseline assessment with a mean age of 17.6?years (range: 11-26?years) at the time of the first CAMELS follow-up. Substance use outcomes included diagnoses as well as lifetime substance use (i.e. alcohol and tobacco use). Results Eleven of 319 (3.4%) CAMELS participants were diagnosed with a substance use disorder at the initial follow-up visit. When compared to the population lifetime rate of 11.4%, the rate of diagnoses in the posttreated sample was significantly lower. Additionally, rates of lifetime alcohol use were lower than population rates at the initial and final follow-up visits. Rates of lifetime tobacco use were similarly lower than lifetime population rates at the initial visit (driven by significantly lower rates in the CBT treatment condition), but higher by the final visit. Furthermore, treatment remission (but not treatment response) was associated with a lower rate of substance use diagnoses at the initial follow-up visit, although rates of lifetime alcohol and tobacco use did not differ by treatment outcome. Conclusions Anxiety treatments confer a beneficial impact on problematic substance use (i.e. diagnoses) as well as on expected substance use (i.e. alcohol and tobacco use) for on average, a period of 6.5?years. En ligne : https://doi.org/10.1111/jcpp.13926 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=532 [article] Substance use outcomes from the Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS) [Texte imprimé et/ou numérique] / Thomas M. OLINO, Auteur ; Anne Marie ALBANO, Auteur ; Courtney P. KEETON, Auteur ; Dara SAKOLSKY, Auteur ; Boris BIRMAHER, Auteur ; John PIACENTINI, Auteur ; Tara S. PERIS, Auteur ; Scott N. COMPTON, Auteur ; Elizabeth GOSCH, Auteur ; Golda S. GINSBURG, Auteur ; Elizabeth L. PINNEY, Auteur ; Philip C. KENDALL, Auteur . - p.910-920. Langues : Anglais (eng) in Journal of Child Psychology and Psychiatry > 65-7 (July 2024) . - p.910-920 Index. décimale : PER Périodiques Résumé : Background Substance use problems and anxiety disorders are both highly prevalent and frequently cooccur in youth. The present study examined the benefits of successful anxiety treatment at 3-12?years after treatment completion on substance use outcomes (i.e. diagnoses and lifetime expected use). Methods The sample was from the Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS), a naturalistic follow-up study to the Child/Adolescent Anxiety Multimodal Study (CAMS) which randomized youth to cognitive behavioral therapy (CBT; Coping cat), medication (sertraline), their combination, or pill placebo. The first CAMELS visit occurred an average of 6.5?years following CAMS randomization. Participants were 319 youth (65.4% of the CAMS sample), aged 7-17?years at CAMS baseline assessment with a mean age of 17.6?years (range: 11-26?years) at the time of the first CAMELS follow-up. Substance use outcomes included diagnoses as well as lifetime substance use (i.e. alcohol and tobacco use). Results Eleven of 319 (3.4%) CAMELS participants were diagnosed with a substance use disorder at the initial follow-up visit. When compared to the population lifetime rate of 11.4%, the rate of diagnoses in the posttreated sample was significantly lower. Additionally, rates of lifetime alcohol use were lower than population rates at the initial and final follow-up visits. Rates of lifetime tobacco use were similarly lower than lifetime population rates at the initial visit (driven by significantly lower rates in the CBT treatment condition), but higher by the final visit. Furthermore, treatment remission (but not treatment response) was associated with a lower rate of substance use diagnoses at the initial follow-up visit, although rates of lifetime alcohol and tobacco use did not differ by treatment outcome. Conclusions Anxiety treatments confer a beneficial impact on problematic substance use (i.e. diagnoses) as well as on expected substance use (i.e. alcohol and tobacco use) for on average, a period of 6.5?years. En ligne : https://doi.org/10.1111/jcpp.13926 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=532

---

1 (1 - 2 / 2)